A detailed history of Bdf Gestion transactions in Abb Vie Inc. stock. As of the latest transaction made, Bdf Gestion holds 60,857 shares of ABBV stock, worth $11.9 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
60,857
Holding current value
$11.9 Million
% of portfolio
1.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $9.42 Million - $11 Million
60,857 New
60,857 $10.4 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $346B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.